Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacalyn Rosenblatt

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
Blood|May 6, 2018
Vaccine therapy in hematologic malignanciesDavid Avigan, Jacalyn Rosenblatt
Best Practice & Research. Clinical Haematology|September 16, 2008
Cellular immunotherapy for multiple myelomaJacalyn Rosenblatt, David Avigan
Expert Review of Vaccines|September 23, 2006
Can leukemia-derived dendritic cells generate antileukemia immunity?Jacalyn Rosenblatt, David Avigan
Cancer Journal (Sudbury, Mass.)|January 30, 2019
Cellular Immunotherapy for Multiple MyelomaJacalyn Rosenblatt, David Avigan
Blood|December 7, 2016
Targeting the PD-1/PD-L1 axis in multiple myeloma: a dream or a reality?Jacalyn Rosenblatt, David Avigan
The New England Journal of Medicine|September 4, 2014
Current treatment for multiple myelomaDavid Avigan, Jacalyn Rosenblatt
Journal of the National Comprehensive Cancer Network : JNCCN|November 11, 2015
Role of Immune Therapies for MyelomaJacalyn Rosenblatt, David Avigan
Hematology/Oncology Clinics of North America|July 19, 2011
Immunotherapy for renal cell carcinomaJacalyn Rosenblatt, David F McDermott
Expert Review of Hematology|June 2, 2018
Cellular immunotherapy as a therapeutic approach in multiple myelomaJessica Liegel, David Avigan, Jacalyn Rosenblatt
Seminars in Oncology|May 19, 2012
Dendritic/tumor fusion cells as cancer vaccinesDavid Avigan, Jacalyn Rosenblatt, Donald Kufe
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
Blood|May 6, 2018
Vaccine therapy in hematologic malignanciesDavid Avigan, Jacalyn Rosenblatt
Best Practice & Research. Clinical Haematology|September 16, 2008
Cellular immunotherapy for multiple myelomaJacalyn Rosenblatt, David Avigan
Expert Review of Vaccines|September 23, 2006
Can leukemia-derived dendritic cells generate antileukemia immunity?Jacalyn Rosenblatt, David Avigan
Cancer Journal (Sudbury, Mass.)|January 30, 2019
Cellular Immunotherapy for Multiple MyelomaJacalyn Rosenblatt, David Avigan
Blood|December 7, 2016
Targeting the PD-1/PD-L1 axis in multiple myeloma: a dream or a reality?Jacalyn Rosenblatt, David Avigan
The New England Journal of Medicine|September 4, 2014
Current treatment for multiple myelomaDavid Avigan, Jacalyn Rosenblatt
Journal of the National Comprehensive Cancer Network : JNCCN|November 11, 2015
Role of Immune Therapies for MyelomaJacalyn Rosenblatt, David Avigan
Hematology/Oncology Clinics of North America|July 19, 2011
Immunotherapy for renal cell carcinomaJacalyn Rosenblatt, David F McDermott
Expert Review of Hematology|June 2, 2018
Cellular immunotherapy as a therapeutic approach in multiple myelomaJessica Liegel, David Avigan, Jacalyn Rosenblatt
Seminars in Oncology|May 19, 2012
Dendritic/tumor fusion cells as cancer vaccinesDavid Avigan, Jacalyn Rosenblatt, Donald Kufe
Pageof 8